Star Imaging and Path Lab
- Market cap
- ₹ 130 Cr.
- P/E
- 6.8x
- P/B
- 1.16x
- 52-week range
- 46 – 152
- ROE
- 24%
- ROCE
- 26%
- Dividend yield
- 0%
- Debt / equity
- 0.18
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- BSE SME
About
Star Imaging and Path Lab Limited is an India-based company, which is primarily engaged in operating pathology and diagnostic centers in New Delhi and Uttar Pradesh. The Company offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography. In the pathology segment, its services include biochemistry, hematology, clinical pathology, histopathology, cytopathology, microbiology, serology, and immunology. Its specialized diagnostic tests cover a wide spectrum of advanced techniques, requiring skilled personnel, precision equipment, and sophisticated technology.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Star Imaging and Path Lab against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)6.8 against a typical 21: cheaper than most peers (1st = cheapest).4th of 34
- Share price, 3 months−18.3% against a typical −7.7%.27th of 33
- Size₹ 130.1 Cr. market value against a typical ₹ 83 Cr. (1st = largest).16th of 34
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 43 | 41 | 45 | 43 |
| Expenses | 31 | 24 | 28 | 27 |
| Operating Profit | 12 | 17 | 17 | 16 |
| OPM % | 27% | 41% | 38% | 37% |
| Other Income | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 |
| Profit before tax | 8 | 13 | 14 | 13 |
| Tax % | 25% | 26% | 26% | 28% |
| Net Profit | 6 | 10 | 10 | 9 |
| EPS in Rs | 41.4 | 7.19 | 5.77 | 5.3 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 14%
- TTM
- 5%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 222%
- TTM
- 21%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 29%
- 3 Years
- 32%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Star Imaging and Path Lab | ₹ 74.10 | ₹ 130 Cr. | 6.8x | 1.2x | 24% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 58x | 12x | — | 8.1% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 59.2x | 8.2x | — | 16.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 85.2x | 7.7x | — | 7.4% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 54.5x | 5.8x | — | 11.3% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 40.8x | 7.7x | — | 9.1% |
Management
- Pawan Gupta
- Executive Chairman of the Board, Managing Director
- Azad Ali
- Chief Financial Officer
- Md Shadab Khan
- Company Secretary, Compliance Officer
- Chhaya Gupta
- Executive Director
- Neelam Ratra
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.